Inteligex Founder and President Dr. Michael Fehlings was invited to be the inaugural guest for the recently launched Optimal NeuroSpine Podcast. In this interview, Dr. Fehlings discusses recent advances in spinal cord injury, the importance of translational research, and the promise of stem cell therapy.
